Corporate information

Top message

  • Representative Director, CEO and CFO
    Hiromi Edahiro

We, TOHO HOLDINGS CO., LTD. and its group companies, conduct pharmaceutical wholesaling, dispensing pharmacy, pharmaceutical manufacturing and sales, and other businesses as a corporate group engaged in the medical, health-care, and nursing care industries. Since our founding, we have been endeavoring to create social value through medical and health-care services.

As Japan enters an era of full-fledged low birthrate and aging population coupled with population decline, a Medical Care Expenditure Regulation Plan has been promoted with the aim of building and maintaining a sustainable social security system. At the same time, guidelines are being issued and system reforms are being advanced to resolve various issues in pharmaceutical distribution. In addition, it is expected that specialty pharmaceuticals, such as biopharmaceuticals and regenerative medical products, will constitute the majority of new drugs to be launched in the future, significantly changing the landscape of pharmaceutical distribution.

Surrounded by this industry environment, we will quickly and properly respond to social changes and challenges and contribute to enriching people’s lives, by supplying health-care-related products such as prescription pharmaceuticals in a stable manner and providing the Company’s unique customer support systems based on the solid business infrastructure and logistics centers we have developed over the years. Also, in a bid to achieve sustainable corporate growth and increase corporate value over the medium to long term, we are working to reduce the effects on the environment by changing our business activities such as optimizing the delivery frequency; to nurture a diverse corporate culture by utilizing a wide array of human resources regardless of gender, nationality, etc.; to strengthen governance to conduct sound business activities; and to take countermeasures against earthquake and pandemic to ensure a stable supply of pharmaceuticals. Through these measures, we are determined to make a greater contribution than ever to all of our stakeholders.

Under the corporate slogan of “Total commitment to good health,” we will continue to evolve and grow, aiming to be a company that is continuously supported by all stakeholders.